The management of upper respiratory tract infections (URTIs) relies on a comprehensive arsenal of URTI therapeutics . The global URTI treatment market, valued at USD 0.03 billion in 2025 and projected to grow to USD 0.07 billion by 2035, reflects the ongoing need for effective and accessible treatment options. URTI therapeutics are tailored to the underlying cause of the infection....